IDIGH  |  Infectious Diseases and Immunity in Global Health Program

Infrastructure to study COVID-19 in a secure environment is creating new possibilities for collaboration and discovery

Scientists discover genetic and immunological causes of 15 percent of life-threatening COVID-19 cases

RI-MUHC researchers lead “real-world” analysis of treatment patterns with checkpoint inhibitors

“I am constantly reminded that community involvement and advocacy are important drivers of scientific and medical knowledge,” says the RI-MUHC trainee

Improving hospital prescribing practices may reduce risk of rehospitalization and death

Adult outpatients with mild symptoms of COVID-19 don’t benefit from taking hydroxychloroquine

Congratulations to researchers and trainees!

A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics

A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease

In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies

RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize

Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality

A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2

RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe

RI-MUHC researcher working with Quebec-based company on a plant-based technique

Congratulations to Marina Machado!

Researchers, advocates and patients gather on Rare Disease Research Day at the RI-MUHC

Study published in the Annals of Internal Medicine

RI-MUHC researchers awarded MUHC Foundation funding for projects with potential impact in a short timeframe

RI-MUHC researchers take leading roles in the initiative